SALUD-M: Acceptance Based Coping Skills for Hispanic/Latinx Military Patients With Type 2 Diabetes
Recruiting · NCT07674628 · Interventional (participants receive a specific treatment) · Lead sponsor: Baylor College of Medicine
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
People of Hispanic or Latino/a/x ("H/L") ethnicity, including US military servicemembers, Veterans, and their families, experience a higher prevalence of type 2 diabetes and more challenges managing diabetes than non-Hispanic White populations. Uncontrolled diabetes is linked with lower quality of life, diabetes-related emotional distress, and severe medical problems. There are many reasons for this difference, including lack of culturally appropriate and bilingual Spanish healthcare services. Additionally, military patients may have additional barrier accessing behavioral health care, which an important part of treatment for many people with diabetes, such as stigma and unique schedule challenges. Therefore, this study aims to overcome these barriers and improve healthcare and health outcomes for H/L military patients. The investigators will test a values-based behavior change program, delivered using video telehealth by a bilingual English-Spanish language health coach. The 10-week Acceptance Based Coping (ABaCo) skills program includes 7 virtually-delivered lessons and was developed by the study team in partnership with civilian community health workers and patients. This study will test the helpfulness of ABaCo delivered by a health coach fluent in English and Spanish to military H/L patients. This randomized controlled trial will examine changes in physical and mental health over 6 months for those who receive ABaCo, compared to those who receive usual healthcare. This project will also identify steps for implementing the ABaCo program in other military treatment facilities. The ultimate goal of this study is to establish a helpful, easy-to-access, widely available program for H/L military patients with type 2 diabetes that improves quality of life and blood sugar control, and lowers distress about diabetes. This study will also identify best approaches to providing ABaCo in military treatment facilities, providing lessons learned to other large healthcare systems.
Who can take part
Inclusion criteria
- Patients ages 18-70
- Diagnosis of T2DM
- Current HbA1c (drawn within 6 months) of 7% or greater (may be taking oral agents or injectables for diabetes control)
- Evidence of avoidance coping (score \<48.4 \[published mean\] on the Acceptance and Action Diabetes Questionnaire) or poor self-management skills (score \< published mean on 2+ subscales of the Summary of Diabetes Self-Care, Activities)
- Self-described as Hispanic/Latino/Latina/Latinx
- Preferred language of English or Spanish, (g) receiving care at the study site clinic.
Exclusion criteria
- End-stage renal disease (on dialysis)
- A medical condition or life circumstance that would contraindicate participation
- Proliferative diabetic retinopathy precluding participation
- Inability to read/comprehend the informed consent process or study instructions
- Pregnant or planning to become pregnant in the next 6 months.
Where it is running
1 location listed across 1 US state.
- Brooke Army Medical Center - San Antonio, Texas, United States